Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration.
作者信息
Chen Wenxin, Wan Guihong, Nguyen Nga, Leung Bonnie, Wen Jun, Collier Michael R, Kwatra Shawn G, Semenov Yevgeniy R
机构信息
Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.
出版信息
JAAD Int. 2022 Aug 18;9:112-115. doi: 10.1016/j.jdin.2022.08.001. eCollection 2022 Dec.
Abstract
摘要
相似文献
1
Identification of cutaneous immune-related adverse events by International Classification of Diseases codes and medication administration.通过国际疾病分类编码和药物管理识别皮肤免疫相关不良事件。
JAAD Int. 2022 Aug 18;9:112-115. doi: 10.1016/j.jdin.2022.08.001. eCollection 2022 Dec.
2
Use of ICD-10-CM T codes in hospital claims data to identify adverse drug events in Taiwan.在医院理赔数据中使用 ICD-10-CM T 代码来识别台湾的药物不良事件。
J Clin Pharm Ther. 2021 Apr;46(2):476-483. doi: 10.1111/jcpt.13308. Epub 2020 Nov 18.
3
Validation of Immune-Related Adverse Event (irAE) Case Definitions in a Real-World Lung Cancer Population.真实世界肺癌人群中免疫相关不良事件（irAE）病例定义的验证
Pharmacoepidemiol Drug Saf. 2025 Feb;34(2):e70100. doi: 10.1002/pds.70100.
4
Identifying Adverse Events Using International Classification of Diseases, Tenth Revision Y Codes in Korea: A Cross-sectional Study.利用国际疾病分类第十版Y编码识别韩国的不良事件：一项横断面研究
J Prev Med Public Health. 2018 Jan;51(1):15-22. doi: 10.3961/jpmph.17.118.
5
Assessment of International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) Code Assignment Validity for Case Finding of Medication-related Hypoglycemia Acute Care Visits Among Medicare Beneficiaries.评估国际疾病分类第 10 次修订版临床修订本（ICD-10-CM）在医疗保险受益人群药物相关性低血糖急症就诊病例发现中的编码赋值有效性。
Med Care. 2022 Mar 1;60(3):219-226. doi: 10.1097/MLR.0000000000001682.
6
ICD-10 codes used to identify adverse drug events in administrative data: a systematic review.用于在行政数据中识别药物不良事件的 ICD-10 代码：系统评价。
J Am Med Inform Assoc. 2014 May-Jun;21(3):547-57. doi: 10.1136/amiajnl-2013-002116. Epub 2013 Nov 12.
7
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.免疫检查点抑制剂引起的多器官免疫相关不良事件及其下游影响：一项回顾性多队列研究。
Lancet Oncol. 2024 Aug;25(8):1053-1069. doi: 10.1016/S1470-2045(24)00278-X. Epub 2024 Jul 15.
8
Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.提高医院药物安全性：基于常规数据中编码的药物不良事件的潜在风险的回顾性研究。
BMC Health Serv Res. 2019 Aug 8;19(1):555. doi: 10.1186/s12913-019-4381-x.
9
Identification and Characterization of Immune Checkpoint Inhibitor-Induced Toxicities From Electronic Health Records Using Natural Language Processing.利用自然语言处理从电子健康记录中识别和描述免疫检查点抑制剂诱导的毒性。
JCO Clin Cancer Inform. 2024 Apr;8:e2300151. doi: 10.1200/CCI.23.00151.
10
Feasibility of Capturing Adverse Events From Insurance Claims Data Using International Classification of Diseases, Tenth Revision, Codes Coupled to Present on Admission Indicators.利用国际疾病分类第十版与入院时指标相匹配的编码从保险索赔数据中捕获不良事件的可行性。
J Patient Saf. 2022 Aug 1;18(5):404-409. doi: 10.1097/PTS.0000000000000932. Epub 2021 Dec 17.
引用本文的文献
1
Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors.免疫检查点抑制剂治疗后皮肤免疫相关不良事件的季节和地理差异。
J Eur Acad Dermatol Venereol. 2025 Jul;39(7):e597-e599. doi: 10.1111/jdv.20484. Epub 2024 Dec 20.
2
Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects.禁食模拟饮食可延缓小鼠的肿瘤生长并减少免疫治疗相关的心血管和全身副作用。
Nat Commun. 2023 Sep 8;14(1):5529. doi: 10.1038/s41467-023-41066-3.
本文引用的文献
1
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.抗程序性细胞死亡蛋白 1 和抗程序性细胞死亡配体 1 治疗的患者中皮肤免疫相关不良事件与生存改善相关。
JAMA Dermatol. 2022 Feb 1;158(2):189-193. doi: 10.1001/jamadermatol.2021.5476.
2
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.免疫检查点抑制剂治疗患者皮肤毒性的发生的流行病学和危险因素：美国人群水平分析。
J Am Acad Dermatol. 2022 Mar;86(3):563-572. doi: 10.1016/j.jaad.2021.03.094. Epub 2021 Apr 2.
3
Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA.预测免疫检查点抑制剂治疗患者中需要住院治疗的严重免疫相关不良事件：来自美国人群水平保险理赔数据库的研究。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001935.
4
Calculating the benefits of a Research Patient Data Repository.计算研究患者数据存储库的益处。
AMIA Annu Symp Proc. 2006;2006:1044.
Zotero 插件